According to the research report titled ‘Global Antifungal Drugs Market: Analysis By Drug Class, By Therapeutic Indications, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, China, Japan, India)’, available with Market Study Report, global antifungal drugs market is expected to grow with a CAGR of 3.70% during 2018-2023.
 

Global antifungal drugs market is witnessing significant growth owing to increasing prevalence of fungal infections such as candidiasis and aspergillosis along with easy availability of innovative antifungals, and growing popularity of over-the-counter drugs. Also, improving awareness regarding deadly antifungal diseases, favorable initiatives by government, growing medical expenditure, and public private partnerships will contribute to market growth over the forecast period.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/1550842/
 

Moreover, surge in aging population, technological developments in pharmaceutical field, and increasing scope in emerging economies like India and China are expected to propel the market growth. On the downside, enhanced fungal resistance, patent expiration of innovator drugs, growing portfolio of antifungal generic drugs, and presence of counterfeit drugs are expected to restrain the market growth to some extent.
 

Global antifungal drugs market is classified with respect to drug class into azoles, polyenes, echinocandins, and others, wherein azoles segment is anticipated to lead the market in the ensuing years. With regards to the therapeutic indications, the market is segmented into dermatophytosis, candidiasis, aspergillosis, and others.
 

Geographically, worldwide antifungal drugs market is segmented into Asia-Pacific, North America, Europe, and rest of the world. North America held the largest market share in 2017, owing to large patient base and highly advanced medical infrastructure in the region.
 

Key players in global antifungal drugs market are Novartis International AG, Abbott Laboratories, Merck & Co., Astellas Pharma, Sanofi, Bayer, GlaxoSmithKline, Kramer Laboratories, and Pfizer.